For the woman who is not planning or desiring further children, sterilization by tubal ligation or hysterectomy would be the most reliable preventative step.

If a young woman needs to start Warfarin during the child-bearing years, it is very important to educate the patient on the potential harm to the unborn child and establish an effective birth control plan.īefore starting therapy, female patients should be asked about their intent to bear children in the future, their birth control methods at present, and their religious beliefs. However, there are situations in women of child-bearing age where Warfarin is still the mainstay of therapy, such as recurrent pulmonary emboli. If possible, another anticoagulant regimen should be used. In most circumstances, Warfarin should be avoided in women of childbearing age unless there is no other option. The actual degree (or percentage) of risk to the unborn child is not known. There is apparently a link between some birth defects and Warfarin taken by the mother during early pregnancy. However, one of the drawbacks for Warfarin is the potential for birth defects and/or hemorrhage in the offspring of mothers taking the drug. Indeed, oral anticoagulation is a vital treatment for certain conditions, such as those listed on the Indications page of his symposium. Warfarin is a safe drug when administered and monitored properly.

Vitamin k antidote dose